These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 25590298)

  • 1. Mechanisms and applications of interleukins in cancer immunotherapy.
    Anestakis D; Petanidis S; Kalyvas S; Nday CM; Tsave O; Kioseoglou E; Salifoglou A
    Int J Mol Sci; 2015 Jan; 16(1):1691-710. PubMed ID: 25590298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukins and cancer immunotherapy.
    Yoshimoto T; Morishima N; Okumura M; Chiba Y; Xu M; Mizuguchi J
    Immunotherapy; 2009 Sep; 1(5):825-44. PubMed ID: 20636026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fighting cancers from within: augmenting tumor immunity with cytokine therapy.
    Pellegrini M; Mak TW; Ohashi PS
    Trends Pharmacol Sci; 2010 Aug; 31(8):356-63. PubMed ID: 20561689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer Cytokines: Biology and Clinical Effects of Interferon-α2, Interleukin (IL)-2, IL-15, IL-21, and IL-12.
    Floros T; Tarhini AA
    Semin Oncol; 2015 Aug; 42(4):539-48. PubMed ID: 26320059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-related interleukins: old validated targets for new anti-cancer drug development.
    Setrerrahmane S; Xu H
    Mol Cancer; 2017 Sep; 16(1):153. PubMed ID: 28927416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The IL-2 cytokine family in cancer immunotherapy.
    Sim GC; Radvanyi L
    Cytokine Growth Factor Rev; 2014 Aug; 25(4):377-90. PubMed ID: 25200249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of novel immunotherapy targeting cancer immune evasion].
    Tamada K
    Gan To Kagaku Ryoho; 2014 Sep; 41(9):1062-5. PubMed ID: 25248888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and therapeutic applications of miRNA-based strategies to cancer immunotherapy.
    Romano G; Kwong LN
    Cancer Metastasis Rev; 2018 Mar; 37(1):45-53. PubMed ID: 29270700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of antigen-specific and non-specific immunotherapy in the treatment of cancer.
    Monjazeb AM; Hsiao HH; Sckisel GD; Murphy WJ
    J Immunotoxicol; 2012; 9(3):248-58. PubMed ID: 22734880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus-mediated interleukin (IL)-24 immunotherapy for cancer.
    Ramesh R; Ioannides CG; Roth JA; Chada S
    Methods Mol Biol; 2010; 651():241-70. PubMed ID: 20686970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs in the Diagnosis and Treatment of Cancer.
    Mansoori B; Mohammadi A; Shirjang S; Baradaran B
    Immunol Invest; 2017 Nov; 46(8):880-897. PubMed ID: 29058545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of cytokines and chemokines in the cancer immunotherapy.
    Amedei A; Prisco D; D' Elios MM
    Recent Pat Anticancer Drug Discov; 2013 May; 8(2):126-42. PubMed ID: 22894642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukins in Thyroid Cancer: From Basic Researches to Applications in Clinical Practice.
    Xi C; Zhang GQ; Sun ZK; Song HJ; Shen CT; Chen XY; Sun JW; Qiu ZL; Luo QY
    Front Immunol; 2020; 11():1124. PubMed ID: 32655554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer.
    Chouaib S; Noman MZ; Kosmatopoulos K; Curran MA
    Oncogene; 2017 Jan; 36(4):439-445. PubMed ID: 27345407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
    Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F
    Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From bench to bedside: the past, present and future of IL-21 immunotherapy.
    Kim AM; Zhao L; Patel TR; Bailey CJ; Bai Q; Wakefield MR; Fang Y
    Med Oncol; 2024 Jun; 41(7):181. PubMed ID: 38900341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Double Face of Exosome-Carried MicroRNAs in Cancer Immunomodulation.
    Alfonsi R; Grassi L; Signore M; Bonci D
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29652798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukins in cancer: from biology to therapy.
    Briukhovetska D; Dörr J; Endres S; Libby P; Dinarello CA; Kobold S
    Nat Rev Cancer; 2021 Aug; 21(8):481-499. PubMed ID: 34083781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting immunometabolism of neoplasms by interleukins: A promising immunotherapeutic strategy for cancer treatment.
    Zhu Z; Parikh P; Zhao H; Givens NT; Beck DB; Willson CM; Bai Q; Wakefield MR; Fang Y
    Cancer Lett; 2021 Oct; 518():94-101. PubMed ID: 34153401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs Reprogram Tumor Immune Response.
    Cao W; Cheng W; Wu W
    Methods Mol Biol; 2018; 1699():67-74. PubMed ID: 29086368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.